Our social responsibility strategy introduces new long-term ambitions in three areas critical to helping improve individual and public health:
Today, one in every 11 people in the world has diabetes, a figure that is projected to rise to one in nine by 2045 if action is not taken.
Diabetes places a great burden on health systems, and we are committed to work with health authorities and other partners in the countries where we operate, to prevent and treat the disease.
The first steps in our
Since its launch in 2009, the A.S.K. campaign has worked to reach the estimated 84 million Americans who are living with prediabetes.
Launched in 2014, Cities Changing Diabetes includes six initiatives that reach, empower and connect more than 75,000 Houstonians to improve diabetes prevention and management.
NovoCare® provides resources to help people using our medicines understand their options, find costs, and connect to affordability support.
Hip-hop legend and TV personality Rev Run and his wife Justine Simmons have teamed up with Novo Nordisk for Ask.Screen.Know., a national program which challenges Americans to find out about their risk of type 2 diabetes and raises awareness of the need for early screening.
More than 30 million Americans have diabetes, but nearly 1 in 4 doesn’t know it. If you're 45 or older, it’s time to ask. Talk to your doctor about getting screened for diabetes.
Visit the A.S.K. website to take a risk factor assessment test, learn about the specific benefits of diabetes screening, and get links to diabetes resources.
Cities are on the front line for diabetes. Two-thirds of people with diabetes globally live in cities. And the highest growth in diabetes is expected to happen in urban settings.1
That’s why we started Cities Changing Diabetes with University College London and Steno Diabetes Center Copenhagen. We believe that the growing prevalence of diabetes, especially in cities, is not inevitable. By partnering with cities, we can help communities understand their unique diabetes challenges, identify areas and populations at greatest risk and design and implement targeted solutions.
We have programs in Houston and in Philadelphia. As of 2020, six initiatives reach, empower and connect more than 75,000 Houstonians to improve diabetes prevention and management.
People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a change in job status due to COVID-19 may be eligible for a free 90-day supply of insulin through Novo Nordisk’s Diabetes Patient Assistance Program.
1. International Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017. 2017: 7-18. Accessed May 2019.